Business
Air Products supplies atmospheric and process gases, equipment and related services to industrial customers.
Air Products' revenue was nearly flat, but project-exit and impairment charges drove a large loss and negative operating margin, overwhelming the recurring industrial-gas base.
The read at a glance✓ Audited against SEC data
- Growth — Revenue declined 0.5%Watch
- Profitability — The company moved from net income of $3.828B to a net loss of $394.5MWatch
- Cash flow — Comparable cash-flow data was unavailableNote
- Margins — Operating margin contracted 4420 bps to -7.29%Watch
- Accounting — Core gas franchise obscured by project-exit chargesWatch
- Insiders — 0 purchases and 3 salesNote
Where the revenue comes from
Fiscal 2025, as Air Products & Chemicals, Inc. reports it. History and quarterly detail are in the app.
- Americas$5.1B
- Asia$3.3B
- Europe$3.0B
- Corporate and other$520.0M
- Middle East and India$135.9M
Leadership changes
From Air Products & Chemicals, Inc.'s own filings, the day they're filed.
- Lisa A. Davis · Directors · departureeff. 2025-11-23
- Sean D. Major · President · departureeff. 2025-07-11
- Eduardo F. Menezes · Chief Executive Officer · appointmenteff. 2025-02-07
Latest filings
- 10-Q · Quarterly report2026-07-30
- 8-K · Company announcement2026-07-30
- 8-K · Company announcement2026-06-30
- 10-Q · Quarterly report2026-04-30
- 8-K · Company announcement2026-04-30
In the full recordFree for 14 days
- What changed🔒
- Insider signal🔒
- Growth quality🔒
- Margins & accounting🔒
- Capital allocation🔒
- Real risks🔒
- The long arc🔒
- Company history🔒
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, sources cited throughout🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask about Air Products & Chemicals, Inc., every answer cited to the official filings🔒
Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.